Treatment of thrice-negative breast cancer in a patient with metabolic syndrome
Breast cancer (BC) remains one of the most common diseases of the female population. According to statistics, breast cancer is detected in every eighth woman. Approximately 20‑24% of breast cancer patients are diagnosed with triple negative breast cancer. Triple‑negative breast cancer is characteriz...
Saved in:
| Main Authors: | G. E. Roitberg, J. V. Dorosh, O. Yu. Anikeeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2021-03-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/674 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS
by: K. A. Simonov, et al.
Published: (2016-02-01) -
Unveiling the impact of lipid metabolism on triple-negative breast cancer growth and treatment options
by: Xin-xian Cai, et al.
Published: (2025-05-01) -
Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer
by: Vishnu Prasath, et al.
Published: (2025-07-01) -
Use of medications in women with triple-negative breast cancer between 2018 and 2019 in a Brazilian public hospital: a retrospective study
by: Monique Cristine da Silva Pires, et al.
Published: (2025-02-01) -
Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry
by: Tomoe Taji, et al.
Published: (2025-06-01)